Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects

  • Authors:
    • Jia Li
    • Guiying Zhang
    • Ting Liu
    • Huan Gu
    • Lu Yan
    • Bolin Chen
  • View Affiliations

  • Published online on: June 18, 2012     https://doi.org/10.3892/etm.2012.613
  • Pages: 442-448
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

This study aimed to construct a novel recombinant expression vector, pcDNA3.1(-)hTERT-shRNA/yCDglyTK. Its bioactivity and antitumor effects were investigated in the SGC7901 human gastric cancer cell line. Interfering RNA (RNAi) targeting human telomerase reverse transcriptase (hTERT) was applied to construct the pYr1.1-hTERT-shRNA vector. The shRNA expression cassette (including U6 promoter) was subcloned into the pcDNA3.1(-)CV-yCDglyTK vector to build a new vector, pcDNA3.1(-)hTERT-shRNA/yCDglyTK, which was identified by restriction enzyme digestion and gene sequencing. All the plasmids were delivered into SGC7901 cells using calcium phosphate nanoparticles (CPNPs). Expression of yCDglyTK and hTERT was detected by immunofluorescence, real-time PCR and western blot analysis. MTT assays were applied to measure the cytotoxic effect of the plasmids with 5-fluorocytosine (5-FC). Cell apoptosis was detected by flow cytometry. Restriction enzyme digestion and gene sequencing confirmed that the recombinant vector pcDNA3.1(-)hTERT-shRNA/yCDglyTK had been successfully constructed. Immunofluorescence, real-time PCR and western blot analysis showed that yCDglyTK was expressed, and that hTERT expression was inhibited in cells transfected with the recombinant vector. The cells transfected with the recombinant vector were the most sensitive to 5-FC and the apoptosis rates of the cells were also increased. The pcDNA3.1(-)hTERTshRNA/yCDglyTK vector was constructed successfully; it was confirmed that targeting hTERT through RNAi could synergize with suicide gene therapy.
View Figures
View References

Related Articles

Journal Cover

September 2012
Volume 4 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li J, Zhang G, Liu T, Gu H, Yan L and Chen B: Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects. Exp Ther Med 4: 442-448, 2012.
APA
Li, J., Zhang, G., Liu, T., Gu, H., Yan, L., & Chen, B. (2012). Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects. Experimental and Therapeutic Medicine, 4, 442-448. https://doi.org/10.3892/etm.2012.613
MLA
Li, J., Zhang, G., Liu, T., Gu, H., Yan, L., Chen, B."Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects". Experimental and Therapeutic Medicine 4.3 (2012): 442-448.
Chicago
Li, J., Zhang, G., Liu, T., Gu, H., Yan, L., Chen, B."Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects". Experimental and Therapeutic Medicine 4, no. 3 (2012): 442-448. https://doi.org/10.3892/etm.2012.613